Cici Xie is an investment analyst on the health care team in the Global Equity Division. She covers the life science tools and diagnostics sector.

Cici has been with T. Rowe Price since 2023, beginning in the U.S. Equity Division. Prior to this, Cici was an intern for the U.S. Equity Division in the summer of 2022. She also was employed by Bank of America Merrill Lynch as an investment banking analyst and associate in mergers and acquisitions.

Cici earned an M.B.A. from Harvard Business School and a B.A. in global business and finance from The Hong Kong University of Science and Technology.